 |
 Previous Article | Next Article 
The Journal of Neuroscience, October 15, 1998, 18(20):8236-8246
Induction of NF- B Activity during Haloperidol-Induced
Oxidative Toxicity in Clonal Hippocampal Cells: Suppression of NF-B
and Neuroprotection by Antioxidants
Anke
Post,
Florian
Holsboer, and
Christian
Behl
Max Planck Institute of Psychiatry, 80804 Munich, Germany
Haloperidol (HP), a dopamine receptor antagonist, is cytotoxic to
mouse clonal hippocampal HT22 cells in a concentration-dependent manner
and causes cell death by oxidative stress. The addition of HP to HT22
cells led to an increase in intracellular peroxides and a
time-dependent drop in the intracellular glutathione levels. HP-induced
oxidative cell death was prevented by the pineal hormone melatonin, its
precursor N-acetyl serotonin, and most effectively by
vitamin E ( -tocopherol). These antioxidants inhibited the intracellular peroxide accumulation and stabilized the glutathione content of HT22 cells after the challenge with HP. At the molecular level, HP specifically induced the DNA binding activity and the transcriptional activity of the redox-sensitive transcription factor
NF- B. This enhanced NF-B activity could be blocked by the
neuroprotective antioxidants. The specific suppression of NF-B by
its inhibitor IB partially protected the cells against HP,
indicating that the activation of NF-B may be involved in HP-induced
oxidative cell death in vitro.
Key words:
haloperidol; oxidative stress; glutathione; NF-B; melatonin; vitamin E
Copyright © 1998 Society for Neuroscience 0270-6474/98/18208236-11$05.00/0
This article has been cited by other articles:
|
|
|
|
 
N. Maruoka, T. Murata, N. Omata, Y. Takashima, Y. Fujibayashi, and Y. Wada
Effects of vitamin E supplementation on plasma membrane permeabilization and fluidization induced by chlorpromazine in the rat brain
J Psychopharmacol,
March 1, 2008;
22(2):
119 - 127.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Kropp, V. Kern, K. Lange, D. Degner, G. Hajak, J. Kornhuber, E. Ruther, H. M. Emrich, U. Schneider, and S. Bleich
Oxidative Stress During Treatment With First- and Second-Generation Antipsychotics
J Neuropsychiatry Clin Neurosci,
May 1, 2005;
17(2):
227 - 231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Lieberman, G. D. Tollefson, C. Charles, R. Zipursky, T. Sharma, R. S. Kahn, R. S. E. Keefe, A. I. Green, R. E. Gur, J. McEvoy, et al.
Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis
Arch Gen Psychiatry,
April 1, 2005;
62(4):
361 - 370.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E Khalifa
Pro-oxidant activity of zuclopenthixol in vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats
Human and Experimental Toxicology,
September 1, 2004;
23(9):
439 - 445.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. Fridmacher, B. Kaltschmidt, B. Goudeau, D. Ndiaye, F. M. Rossi, J. Pfeiffer, C. Kaltschmidt, A. Israel, and S. Memet
Forebrain-Specific Neuronal Inhibition of Nuclear Factor-{kappa}B Activity Leads to Loss of Neuroprotection
J. Neurosci.,
October 15, 2003;
23(28):
9403 - 9408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ryu, J. Lee, K. Zaman, J. Kubilis, R. J. Ferrante, B. D. Ross, R. Neve, and R. R. Ratan
Sp1 and Sp3 Are Oxidative Stress-Inducible, Antideath Transcription Factors in Cortical Neurons
J. Neurosci.,
May 1, 2003;
23(9):
3597 - 3606.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nava, Y. Quiroz, N. Vaziri, and B. Rodriguez-Iturbe
Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats
Am J Physiol Renal Physiol,
March 1, 2003;
284(3):
F447 - F454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Bhakar, L.-L. Tannis, C. Zeindler, M. P. Russo, C. Jobin, D. S. Park, S. MacPherson, and P. A. Barker
Constitutive Nuclear Factor-kappa B Activity Is Required for Central Neuron Survival
J. Neurosci.,
October 1, 2002;
22(19):
8466 - 8475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Morris, D. A. Evans, J. L. Bienias, C. C. Tangney, D. A. Bennett, N. Aggarwal, R. S. Wilson, and P. A. Scherr
Dietary Intake of Antioxidant Nutrients and the Risk of Incident Alzheimer Disease in a Biracial Community Study
JAMA,
June 26, 2002;
287(24):
3230 - 3237.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yabe, D. Wilson, and J. P. Schwartz
NFkappa B Activation Is Required for the Neuroprotective Effects of Pigment Epithelium-derived Factor (PEDF) on Cerebellar Granule Neurons
J. Biol. Chem.,
November 9, 2001;
276(46):
43313 - 43319.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Shamir, Y. Barak, I. Shalman, M. Laudon, N. Zisapel, R. Tarrasch, A. Elizur, and R. Weizman
Melatonin Treatment for Tardive Dyskinesia: A Double-blind, Placebo-Controlled, Crossover Study
Arch Gen Psychiatry,
November 1, 2001;
58(11):
1049 - 1052.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Ernfors
Nuclear Factor-{kappa}B to the Rescue of Cytokine-induced Neuronal Survival
J. Cell Biol.,
January 24, 2000;
148(2):
223 - 226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Lezoualc’h, S. Engert, B. Berning, and C. Behl
Corticotropin-Releasing Hormone-Mediated Neuroprotection against Oxidative Stress Is Associated with the Increased Release of Non-amyloidogenic Amyloid {beta} Precursor Protein and with the Suppression of Nuclear Factor-{kappa}B
Mol. Endocrinol.,
January 1, 2000;
14(1):
147 - 159.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H. Wellmann, B. Kaltschmidt, and C. Kaltschmidt
Retrograde Transport of Transcription Factor NF-kappa B in Living Neurons
J. Biol. Chem.,
April 6, 2001;
276(15):
11821 - 11829.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
